BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, offering promising progress throughout various medical and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, much more reputable alternative for therapeutic use, significa